Your Podsite trial is ending soon. Put the final touches on it with our tips on how to make a great podcast website.

Claim your custom domain name todayClaim your domain

S8: #076: Fighting Cancer Through Early Detection of Biomarkers

26 minutes

Turning autoantibodies into an early-warning system to beat cancer

In episode 74, we spoke about early detection of skin cancer with Erik de Heus, the CEO of SkinVision. In that episode we talked about a smartphone app that uses AI to determine the likelihood that a mole or mark on your skin could be malignant. That technology has reviewed millions of images and has helped detect cancer in tens of thousands of people around the world. It’s a great solution and it’s making a huge impact and it will continue to hold a vital place in our fight against skin cancer. But what about cancers below our skin’s surface? What tools do we have to detect and fight those cancers that we can’t see and that may be developing inside us?

Is there a way to detect those cancers even before they form a cluster of cells large enough to be detected through a biopsy or scan?

What if we could enlist the power of our own immune system to create a sort of early warning system that could alert us when cancerous cells are present.

Well, the good news is that such a technology does exist, and it’s being used to detect cancer 4 years earlier, or sometimes even more, for a wide range of solid tumor types. And all it requires is a simple blood test.

Our guest today is going to share how these technologies work, and how they are changing the way with think about the progression, detection and treatment of cancer.

With me to talk about it is Dr Adam M Hill, he is the CEO of a leading cancer detection company called Oncimmune. Adam is a both a Clinician and Mechanical Engineer, and has spent his career at the interface of industry, academia and health systems. Early in his career, he trained in surgery in the British Army and he helped a Formula One team become a developer of health technology.

Over the last 5 years, Adam has been an early stage investor in, and advisor to, a number of health technology startups. He is also a Visiting Professor in Global Health Innovation at Imperial College London. We cover a lot of ground in this episode and Adam and his team have developed a PDF that contains the key details we talk about in this program, so be sure to grab a copy of that as well.


Today's Topics:

  • Brief introduction of Cancer in the biology and the foundation behind the technology
  • Biomarker antigens & novel approaches in detecting cancer cells and its impact in Cancer Care pathways and treatment
  • The possible changes in the paradigm of early Cancer detection, diagnosis, and post care treatment
  • How viable is this technology to the market and will it be in tandem with other technologies
  • What other recent breakthroughs in technology that relates to early Cancer detection


Links and Resources Mentioned:


This episode of Digital Health Today is made possible thanks to our sponsors. Thank you!

Learn more about your ad choices. Visit megaphone.fm/adchoices

More episodes from Digital Health Today 360 with Dan Kendall

S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella

"In this episode, I'm excited to introduce you to yet another outstanding health innovation leader who is hosting another new show on Digital Health Today. His degrees are in engineering …

S11: #109 Introducing the Host of the new Digital Therapeutics Podcast: Eugene Borukhovich

In this episode, I have the pleasure of introducing you to one of the health sectors leading innovators, and probably one of the best known and, dare I say it, most loved, leaders I’ve had …

Coffee Talk: How Corporations Adapt in the Face of New Challenges

In this episode I welcome two executives from Bayer G4A. Bayer G4A has been a longtime sponsor of Digital Health Today. I caught up with Dominick Kennerson, Global Head G4A, Digital Health …

Coffee Talk: How Digital Health Startups Respond and Thrive in a Global Pandemic

Imagine this: You’re the founder of a digital health startup. You’ve been carefully selected and invited to participate in a brand new accelerator in …

S11: #108 - What the Clearance of Akili's EndeavorRX Means for the Company, Users and the Industry

If you’ve been tuned into nearly any news channel recently, you’ve probably seen the announcement by Akili about the clearance they announced on June 15 for their product EndeavorRX. It is …

Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for innovative companies to grow and partner with a global …

How you can listen to this podcast

You can listen to episodes right here on the website, or if you prefer, in a podcast app. Listening in an app makes it easier to keep track of what you’ve already heard, listen without using your data plan and many other conveniences.

Recommended apps
Start listening to S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella
28:29
Start listening to S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella
28:29